NCT00000662View on ClinicalTrials.gov

A Treatment IND for Retrovir Brand Zidovudine (AZT) Therapy of Pediatric Patients With HIV Disease

NACompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Primary Completion Date

May 31, 1993

Study Completion Date

May 31, 1993

Conditions
HIV Infections
Interventions
DRUG

Zidovudine

Trial Locations (1)

27709

Glaxo Wellcome Inc, Research Triangle Park

Sponsors

Collaborators (1)

Glaxo Wellcome
All Listed Sponsors
collaborator

Glaxo Wellcome

INDUSTRY

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00000662 - A Treatment IND for Retrovir Brand Zidovudine (AZT) Therapy of Pediatric Patients With HIV Disease | Biotech Hunter | Biotech Hunter